Showing results (111-120 of 148) with videos related to

Sort By:
Pageof 15
Drug Metabolism and Pharmacokinetics|April 8, 2016
Rifampin enhances cytochrome P450 (CYP) 2B6-mediated efavirenz 8-hydroxylation in healthy volunteersDoo-Yeoun Cho, Joan H Q Shen, Suzanne M Lemler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2008
Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapyYan Jin, Daniel F Hayes, Lang Li, et al.
British Journal of Clinical Pharmacology|November 14, 2006
Possible interethnic differences in quinidine-induced QT prolongation between healthy Caucasian and Korean subjectsJae-Gook Shin, Won-Ku Kang, Ji-Hong Shon, et al.
Breast Cancer Research and Treatment|December 13, 2016
Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancerJason D Robarge, Zereunesay Desta, Anne T Nguyen, et al.
Breast Cancer Research and Treatment|October 9, 2007
Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitorsN Lynn Henry, Jon T Giles, Dennis Ang, et al.
Journal of Clinical Pharmacology|January 19, 2010
Composite functional genetic and comedication CYP2D6 activity score in predicting tamoxifen drug exposure among breast cancer patientsSilvana Borges, Zeruesenay Desta, Yan Jin, et al.
Breast Cancer Research and Treatment|January 21, 2009
Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohortN Lynn Henry, James M Rae, Lang Li, et al.
Clinical Pharmacology and Therapeutics|July 4, 2006
Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatmentSilvana Borges, Zeruesenay Desta, Lang Li, et al.
Pageof 15